Expression of estrogen related proteins in hormone refractory prostate cancer: Association with tumor progression

Journal of Urology

Volumn 184, Issue 5, 2010, Pages 2172-2178

  Celhay, Olivier ^a   Yacoub, Mokrane ^a   Irani, Jacques ^a   Dore, Bertrand ^a   Cussenot, Olivier ^b   Fromont, Gaelle ^a,b  

^a Section of Radiology   (France)

^b Centre de Recherche sur les Pathologies Prostatiques   (France)

Author keywords

Androgen antagonists; Estrogens; Gene expression; Prostate; Prostatic neoplasms

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; AROMATASE; CRK ASSOCIATED SUBSTRATE PROTEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; KI 67 ANTIGEN; STEROID 5ALPHA REDUCTASE 1; STEROID 5ALPHA REDUCTASE 2; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ANDROGEN METABOLISM; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER RELAPSE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN METABOLISM; HORMONE SENSITIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; STROMA CELL; TISSUE MICROARRAY; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATIC NEOPLASMS; PROTEIN SYNTHESIS; TREATMENT FAILURE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANDROGENS; ANTINEOPLASTIC AGENTS, HORMONAL; DISEASE PROGRESSION; ESTROGENS; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; TREATMENT FAILURE;

EID: 77957843261     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.06.089     Document Type: Article

References (30)

1. B.J. Feldman, and D. Feldman The development of androgen-independent prostate cancer Nat Rev Cancer 1 2001 34
2. P. McCall, L.K. Gemmell, and R. Mukherjee Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients Br J Cancer 98 2008 1094
3. J.L. Mohler, C.W. Gregory, and O.H. Ford The androgen axis in recurrent prostate cancer Clin Cancer Res 10 2004 440
4. F.K. Habib, M. Ross, and C.W. Bayne The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis Clin Cancer Res 9 2003 1815
5. L.N. Thomas, C.B. Lazier, and R. Gupta Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer Prostate 63 2005 231
6. M.A. Titus, C.W. Gregory, and O.H. Ford Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer Clin Cancer Res 11 2005 4365
7. H. Bonkhoff, T. Fixemer, and I. Hunsicker Estrogen receptor expression in prostate cancer and premalignant prostatic lesions Am J Pathol 155 1999 641
8. A. Latil, I. Bieche, and D. Vidaud Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays Cancer Res 61 2001 1919
9. I. Leav, K.M. Lau, and J.Y. Adams Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma Am J Pathol 159 2001 79
10. S.J. Ellem, J.F. Schmitt, and J.S. Pedersen Local aromatase expression in human prostate is altered in malignancy J Clin Endocrinol Metab 89 2004 2434
11. G. Fromont, M. Yacoub, and A. Valeri Differential expression of genes related to androgen and estrogen metabolism in hereditary versus sporadic prostate cancer Cancer Epidemiol Biomarkers Prev 17 2008 1505
12. Y. Takase, M.H. Levesque, and V. Luu-The Expression of enzymes involved in estrogen metabolism in human prostate J Histochem Cytochem 54 2006 911
13. R.B. Shah, R. Mehra, and A.M. Chinnaiyan Androgen-independent prostate cancer is a heterogeneous group of disease Lessons from a rapid autopsy program Cancer Res 64 2004 9209
14. H.I. Scher, S. Halabi, and I. Tannock Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group J Clin Oncol 26 2008 1148
15. S.S. Singh, D.C. Mehedint, and O.H. Ford Feasibility of constructing tissue microarrays from diagnostic prostate biopsies Prostate 67 2007 1011
16. G. Fromont, L. Chene, and M. Vidaud Differential expression of 37 selected genes in hormone-refractory prostate cancer using quantitative TaqMan real-time RT-PCR Int J Cancer 114 2005 174
17. T. Visakorpi, E. Hyytinen, and P. Koivisto In vivo amplification of the androgen receptor gene and progression of human prostate cancer Nat Genet 9 1995 401
18. H.K. Lin, Y.C. Hu, and L. Yang Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers J Biol Chem 278 2003 50902
19. H. Bonkhoff, and R. Berges The evolving role of oestrogens and their receptors in the development and progression of prostate cancer Eur Urol 55 2009 333
20. O. Cussenot, A.R. Azzouzi, and N. Nicolaiew Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens J Clin Oncol 25 2007 3596
21. B. Price, B. Stein, and P. Sieber Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial J Urol 176 2006 965
22. S. Bourguiba, S. Lambard, and S. Carreau Steroids control the aromatase gene expression in purified germ cells from the adult male rat J Mol Endocrinol 31 2003 83
23. M.R. Smith, D. Kaufman, and D. George Selective aromatase inhibition for patients with androgen-independent prostate carcinoma Cancer 95 2002 1864
24. S.J. Ellem, and G.P. Risbridger Treating prostate cancer: a rationale for targeting local oestrogens Nat Rev Cancer 7 2007 621
25. W.A. Ricke, S.J. McPherson, and J.J. Bianco Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling FASEB J 22 2008 1512
26. T. van Agthoven, A.M. Sieuwerts, and M.E. Meijer-van Gelder Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance J Clin Oncol 27 2009 542
27. S. Cabodi, L. Moro, and G. Baj p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells J Cell Sci 117 2004 1603
28. G. Fromont, G. Vallancien, and P. Validire BCAR1 expression in prostate cancer: association with 16q23 LOH status, tumour progression and EGFR/KAI1 staining Prostate 67 2007 268
29. L.C. Li, R. Chui, and K. Nakajima Frequent methylation of estrogen receptor in prostate cancer: correlation with tumour progression Cancer Res 60 2000 702
30. A. Migliaccio, G. Castoria, and M. Di Domenico Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation EMBO J 19 2000 5406